You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: February 27, 2020

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca Pharmaceuticals LP v. Apotex Inc. (D. Del. 2007)

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

AstraZeneca Pharmaceuticals LP v. Apotex Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-12-11
Court District Court, D. Delaware Date Terminated 2010-07-13
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand Defendant Referred To
Patents 3,878,217; 4,254,129; 4,430,343; 4,661,491; 4,743,450; 5,098,715; 5,164,194; 5,424,078; 5,681,590; 5,849,726; 5,880,283; 5,994,329; 6,008,207; 6,015,801; 6,090,410; 6,149,940; 6,194,004; 6,225,294; 6,316,460; 6,562,873; 6,627,210; 6,641,834; 6,673,337; 6,858,618
Attorneys Brian J. Sodikoff; Charles E. Lipsey; Colleen Tracy; Craig M. Kuchii; David Ellis Moore; Doungamon Fon Muttamara-Walker; Ford F. Farabow; Henry J. Renk; Jeremy C. Daniel; Joanna R. Stevason; John Aron Carnahan; Kenneth Laurence Dorsney; Kenneth M. Frankel; Laurie A. Haynie; Mary W. Bourke; Richard L. Horwitz; Robert B. Breisblatt; Stephen P. Benson; York M. Faulkner
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca Pharmaceuticals LP v. Apotex Inc.
Biologic Drugs cited in AstraZeneca Pharmaceuticals LP v. Apotex Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for AstraZeneca Pharmaceuticals LP v. Apotex Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2008-04-28 47 Redacted Document ;s:714: External link to document
2008-11-24 75 8The Florida action relates to U.S. Patent No. 6,316,460, for which AstraZeneca is the owner and/… States Patent and Trademark Office took to grant a patent, a manufacturer's patent term was…in a patent or the use of which is claimed in a patent before the expiration of such patent. (Emphasis…section) alleging patent infringement. AstraZeneca holds all substantial rights in U.S. Patent No. RE37,314…and testing (a use) of a patented product prior to the expiration of the patent an act of infringement, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.